Skip to main content
SpringerLink
Log in

Decision Resources predicts that the bipolar disorder drug market will decline by more than $US1 billion over the next decade

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources Inc.Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018. Media Release: 5 Nov 2009. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decision Resources predicts that the bipolar disorder drug market will decline by more than $US1 billion over the next decade. Pharmacoecon. Outcomes News 591, 14 (2009). https://doi.org/10.2165/00151234-200905910-00042

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905910-00042

Keywords

Search

Navigation